Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-07-08Clinical Trial Update: Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose Reduction [Phase 4]
Phase 4 trial comparing active conventional therapy to three biologic treatments in early rheumatoid arthritis with subsequent dose reductio…
-
CLINICAL_TRIALS trial_result · 2022-07-08Clinical Trial Update: Efficacy and Safety of Colquhounia Root Tablet in Patients With Rheumatoid Arthritis [Phase 4]
Phase 4 clinical trial update evaluating efficacy and safety of Colquhounia Root Tablet in patients with rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2022-07-08Clinical Trial Update: Dose Reduction for Early Rheumatoid Arthritis Patients With Low Disease Activity [Phase 4]
Phase 4 trial update examining dose reduction for early rheumatoid arthritis patients with low disease activity.
-
CLINICAL_TRIALS trial_result · 2022-07-07Clinical Trial Update: Study to Compare PK & Safety of Advixa With Humira in Healthy, Adult Subject Followed by Efficacy & Safety Study in RA Patients [Phase 2, Phase 3]
A multi-phase study comparing Advixa to Humira in healthy adults and later efficacy/safety assessment in rheumatoid arthritis patients is un…
-
CLINICAL_TRIALS trial_result · 2022-06-10Clinical Trial Update: Open-label, Extension Study of CDP870 in Patients With Rheumatoid Arthritis [Phase 3]
Open-label extension study results for CDP870 in rheumatoid arthritis completed Phase 3 trial.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-06-07Clinical Trial Update: Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis [Phase 3]
Phase 3 trial update for olokizumab in moderately to severely active rheumatoid arthritis; results posted indicating efficacy and safety dat…
-
CLINICAL_TRIALS trial_result · 2022-05-17Clinical Trial Update: The Long-term Safety and Efficacy of CDP6038 (Olokizumab) With Active Rheumatoid Arthritis [Phase 2]
Phase 2 trial update on the long-term safety and efficacy of olokizumab (CDP6038) in active rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2022-05-12Clinical Trial Update: Study of the Efficacy and Safety of BCD-089 in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis [Phase 3]
Phase 3 trial evaluating BCD-089 in combination with methotrexate for active rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-09Clinical Trial Update: Study of Safety and Efficacy of HLX01+MTX in Patients With Rheumatoid Arthritis [Phase 3]
Phase 3 clinical trial evaluating HLX01 plus methotrexate in moderately to severely active rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-09Clinical Trial Update: A Randomised, Double-blind, Phase I/II Study to Evaluate the PK, PD, Safety, and Efficacy Between HLX01 and Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis and Inadequate Response to Treatment With DMARDs [Phase 1, Phase 2]
A randomized, double-blind Phase I/II trial comparing HLX01 to rituximab in patients with moderate to severe rheumatoid arthritis who have i…
-
CLINICAL_TRIALS trial_result · 2022-05-06Clinical Trial Update: Natrunix Versus Methotrexate in Rheumatoid Arthritis [Phase 2]
Phase 2 clinical trial update comparing Natrunix to methotrexate in rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2022-05-05Clinical Trial Update: Auto-injector Real Life Handling in Patients [Phase 3]
A Phase 3 clinical trial evaluating auto-injector real-life handling in patients with rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-26Clinical Trial Update: Assessing Withdrawal of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis [Phase 4]
A Phase 4 clinical trial evaluating withdrawal of disease-modifying antirheumatic drugs in rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-14Clinical Trial Update: Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056 [Phase 2]
Phase 2 open-label study of CDP6038 (Olokizumab) in rheumatoid arthritis completed; results posted.
-
CLINICAL_TRIALS trial_result · 2022-04-11Clinical Trial Update: Novel Form of Acquired Long QT Syndrome [Phase 4]
A Phase 4 clinical trial update for a novel form addressing Acquired Long QT Syndrome with additional conditions listed; current status is u…
-
CLINICAL_TRIALS trial_result · 2022-04-07Clinical Trial Update: Study of Two Doses of ABX464 in Participants With Moderate to Severe Rheumatoid Arthritis [Phase 2]
Phase 2 clinical trial update for two doses of ABX464 in moderate to severe rheumatoid arthritis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: Tolerance and Effectiveness of Cell Therapy by Autologous Apoptotic Cells in the Treatment of Rheumatoid Arthritis [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating autologous apoptotic cell therapy for rheumatoid arthritis; current status unknown.
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: MTX Hold During Covid-19 Booster [Phase 3]
Phase 3 clinical trial update investigating hold of methotrexate during COVID-19 booster in rheumatoid arthritis patients.
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: Study of CE-224,535 A Twice Daily Pill To Control Rheumatoid Arthritis In Patients Who Have Not Totally Improved With Methotrexate [Phase 2]
Phase 2 study evaluating CE-224,535 taken twice daily for rheumatoid arthritis in patients not fully responsive to methotrexate; trial compl…
-
CLINICAL_TRIALS trial_result · 2022-03-22Clinical Trial Update: Tripterygium Wilfordii Hook F and Methotrexate for Postmenopausal Women With Rheumatoid Arthritis [Phase 2, Phase 3]
A Phase 2/3 trial evaluating Tripterygium wilfordii Hook F in combination with methotrexate for postmenopausal women with rheumatoid arthrit…
-
CLINICAL_TRIALS trial_result · 2022-03-22Clinical Trial Update: Phase 1/2a Clinical Trial to Assess the Safety of HB-adMSCs for the Treatment of Rheumatoid Arthritis [Phase 1, Phase 2]
A Phase 1/2a trial evaluating the safety of HB-adMSCs for rheumatoid arthritis has completed enrollment and posted results.
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: Comorbidities and Outcomes in Early Rheumatoid Arthritis
A completed clinical trial updating comorbidities and outcomes in early rheumatoid arthritis, with posted results.
-
CLINICAL_TRIALS trial_result · 2022-03-11Clinical Trial Update: MYL-1401A Efficacy and Safety Comparability Study to Humira® [Phase 3]
Phase 3 trial comparing MYL-1401A to Humira for psoriasis, arthritis, and psoriatic arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-28Clinical Trial Update: Safety and Efficacy of AMG 827 in Subjects With RA [Phase 2]
Phase 2 clinical trial of AMG 827 in rheumatoid arthritis was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2022-02-23Clinical Trial Update: Tolerogenic Dendritic Cell Therapy for Rheumatoid Arthritis [Phase 1, Phase 2]
A clinical trial update on tolerogenic dendritic cell therapy for rheumatoid arthritis spanning Phase 1 and Phase 2.